Clinical Trials in Maryland

Showing 2041-2060 of 23,284 trials

Multicenter Clinical Trial of a Phakic Implantable Collamer® Lens (ICL)

NCT04283149

This objective of this study is to evaluate the safety, and to collect supportive data on effectiveness of the EVO/EVO+ Visian® Implantable Collamer® Lens (ICL) in study participants who have a diagnosis of myopia or myopia with astigmatism. Primary study analysis will be evaluated when 300 primary eyes complete 6 months of follow-up. Final study analysis will be assessed when all treated eyes complete 36 months of follow-up.

MyopiaMyopic Astigmatism

Staar Surgical Company327 participantsStarted Jan 2020

Phoenix, Arizona, United States • Honolulu, Hawaii, United States • Indianapolis, Indiana, United States +11 more locations

Active Not RecruitingPhase 313 miles

Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)

NCT06151197

This study will assess the efficacy, safety, and tolerability of EN3835 compared to placebo in the treatment of PFI (also known as Ledderhose disease).

Plantar FibromatosisLedderhose Disease

Endo Pharmaceuticals418 participantsStarted Nov 2023

Mesa, Arizona, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +63 more locations

Multicenter Clinical Trial of a Phakic Implantable Collamer® Lens (ICL)

Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)

Find Trials by Condition in Maryland

Study of VYD2311 for the Prevention of COVID-19

Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI)

ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)

A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Transcriptomic Profile Changes in Benign Tracheal Stenosis: Wedge Resection vs. Radial Incision

Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study

Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome

Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma